Metoprolol-induced psoriatic nail disease.
We describe the development of psoriatic nail disease due to metoprolol in a 58-year-old woman who was being treated for cardiac arrhythmias. The nail condition was unresponsive to topical and systemic treatments but resolved completely with the withdrawal of metoprolol. The reaction recurred with drug rechallenge and resolved when the drug was ceased.
The Royal Melbourne Hospital, Parkville, Vic. 3050, Australia. a.d.gin@hotmail.com
Alexander
A
Gin
Douglas
D
Gin
Rodney
R
Sinclair
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects*; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced*; D011565:Psoriasis / Q000139:chemically induced*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D008790:Metoprolol